过去一年中添加的文章，按日期排序

Phase 1 study of multiple intracerebral doses of a neural stem cell-based oncolytic virotherapy for treatment of recurrent high-grade gliomas.

J Portnow, B Badie, S Blanchard, M D'Apuzzo, A Nath… - 2024 - ascopubs.org
37 天前 - … cells as well as induce anti-tumor immune responses. … a tumor-selective, conditionally
replicating adenovirus (CRAd… the safety and feasibility of intracerebrally administering up …
相关文章

STEM CELL DELIVERED ONCOLYTIC VIRO-IMMUNOTHERAPY FOR TREATMENT OF GLIOMA AND OVARIAN CANCER: BENCH TO BEDSIDE

KS Aboody, G Ngai, J Lara, DT Curiel, M Lesniak… - Cytotherapy, 2024 - Elsevier
44 天前 - … tumor cell lysis and stimulate an anti-tumor immune … of a conditionally replication
competent adenovirus (CRAd-S-… (IP) ovarian cancer metastases after IP NSC administration. …
相关文章

Turning up the heat: Oncolytic virus MEM-288 induces anti-tumoral immune response in pre-clinical models of high grade serous ovarian cancer (190)

P Peters, R Whitaker, F Lim… - Gynecologic …, 2023 - gynecologiconcology-online.net
308 天前 - … This conditionally replicative virus encodes IFN-β and a … to IP administration of
saline, GFP-expressing adenovirus (Adv-… was used to evaluate immune populations in the tumor …
相关文章